Literature DB >> 23314152

On the geometric modeling approach to empirical null distribution estimation for empirical Bayes modeling of multiple hypothesis testing.

Baolin Wu1.   

Abstract

We study the geometric modeling approach to estimating the null distribution for the empirical Bayes modeling of multiple hypothesis testing. The commonly used method is a nonparametric approach based on the Poisson regression, which however could be unduly affected by the dependence among test statistics and perform very poorly under strong dependence. In this paper, we explore a finite mixture model based geometric modeling approach to empirical null distribution estimation and multiple hypothesis testing. Through simulations and applications to two public microarray data, we will illustrate its competitive performance.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23314152      PMCID: PMC3580033          DOI: 10.1016/j.compbiolchem.2012.12.001

Source DB:  PubMed          Journal:  Comput Biol Chem        ISSN: 1476-9271            Impact factor:   2.877


  20 in total

1.  Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.

Authors:  J M Heddleston; Q Wu; M Rivera; S Minhas; J D Lathia; A E Sloan; O Iliopoulos; A B Hjelmeland; J N Rich
Journal:  Cell Death Differ       Date:  2011-08-12       Impact factor: 15.828

Review 2.  Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?

Authors:  Aleksandra Rizo; Edo Vellenga; Gerald de Haan; Jan Jacob Schuringa
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

Review 3.  Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug.

Authors:  Alan G Ramsay; John G Gribben
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

4.  Glucocorticoid inhibition of antigen-induced inositol phosphate formation: possible involvement of phosphatases.

Authors:  E Her; U Zor
Journal:  J Basic Clin Physiol Pharmacol       Date:  1991 Jul-Sep

5.  Vascular cell adhesion molecule-1 induced by human T-cell leukaemia virus type 1 Tax protein in T-cells stimulates proliferation of human T-lymphocytes.

Authors:  Hélène Valentin; Samir Hamaia; Stéphane König; Louis Gazzolo
Journal:  J Gen Virol       Date:  2001-04       Impact factor: 3.891

6.  SET-induced calcium signaling and MAPK/ERK pathway activation mediate dendritic cell-like differentiation of U937 cells.

Authors:  A Kandilci; G C Grosveld
Journal:  Leukemia       Date:  2005-08       Impact factor: 11.528

Review 7.  IDH mutations in glioma and acute myeloid leukemia.

Authors:  Lenny Dang; Shengfang Jin; Shinsan M Su
Journal:  Trends Mol Med       Date:  2010-08-05       Impact factor: 11.951

8.  Divergence between immunosuppression and immunocompetence during virus-induced leukemogenesis.

Authors:  J Cerny; R F McAlack; W S Geglowski; H Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

9.  Gene expression correlates of clinical prostate cancer behavior.

Authors:  Dinesh Singh; Phillip G Febbo; Kenneth Ross; Donald G Jackson; Judith Manola; Christine Ladd; Pablo Tamayo; Andrew A Renshaw; Anthony V D'Amico; Jerome P Richie; Eric S Lander; Massimo Loda; Philip W Kantoff; Todd R Golub; William R Sellers
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

10.  Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias.

Authors:  S Zhao; M Konopleva; M Cabreira-Hansen; Z Xie; W Hu; M Milella; Z Estrov; G B Mills; M Andreeff
Journal:  Leukemia       Date:  2004-02       Impact factor: 11.528

View more
  1 in total

1.  Local false discovery rate estimation using feature reliability in LC/MS metabolomics data.

Authors:  Elizabeth Y Chong; Yijian Huang; Hao Wu; Nima Ghasemzadeh; Karan Uppal; Arshed A Quyyumi; Dean P Jones; Tianwei Yu
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.